SETP4 Myeloproliferative Neoplasms

[OS3-12D-3] Distinctive clinical and molecular features in absolute triple-negative essential thrombocythemia

Tadaaki Inano¹, Marito Araki², Soji Morishita², Tomonori Ochiai¹, Kyohei Misawa¹, Yasutaka Fukuda¹, Naoko Midorikawa¹, Mai Nudejima¹, Masafumi Ito³, Satoshi Osaga⁴, Yoko Edahiro¹, Misa Imai^1,5, Teppei Taguchi¹, Maho Okuda^1,6, Akimichi Ohsaka², Norio Komatsu¹ (1.Hematol, Juntendo Univ. Graduate School of Med., Tokyo, Japan, 2.Transfusion Med. & Stem Cell Regu., Juntendo Univ., 3.Pathol, Japanese Red Cross Nagoya Daiichi Hosp., Aichi, Japan, 4.Clinical Research Management Center, Nagoya City Univ. Hosp., Aichi, Japan, 5.Center for Development and Research of Cancer Med., Juntendo Univ., 6.Institute for Environmental and Gender Specific Med., Juntendo Univ.)